Search

everythinglearnresearchcommunity

for

Search:↓

Canadian lawsuits involving 5-alpha-reductase inhibitors are related to persistent erectile dysfunction side effects, with no judgments against companies yet.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

5α-Reductase inhibitors can negatively affect male sexual function and, in some cases, significantly reduce sperm count, but these effects may be reversible.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Minoxidil caused a severe rash in a patient, which improved after stopping the drug.

A reliable method was developed to measure aristolochic acid-I in rat blood.

Minoxidil can stop the growth of ovarian cancer cells without harming the heart.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

2-Hydroxy-1,4-naphthoquinone is a strong 5α-reductase inhibitor.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

The study created a model to help design new inhibitors for steroidal 5α-reductase enzymes.

Finasteride effectively inhibits the enzyme steroid 5 alpha-reductase II.

Minoxidil is strongly linked to heart problems, and machine learning can improve drug safety checks.

Finasteride is more effective and satisfactory than montelukast for treating moderate acne in women.

Minoxidil boosts plasma renin activity, influenced by control plasma renin activity and changes in sympathetic tone.

Pexidartinib often causes liver issues and fatigue, especially in women.

Clofazimine may be effective for treating ashy dermatosis.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Finasteride blocks deoxycorticosterone's anticonvulsant effects in infant rats, but indomethacin doesn't.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.

Oral minoxidil effectively treats female pattern hair loss and is a good alternative to topical minoxidil.

Low-dose oral minoxidil and spironolactone combo effectively reduces hair loss and improves hair density in women.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.